| Key Financial Ratios of Eris Lifesciences (in Rs. Cr.) |
Mar 23 |
Mar 22 |
Mar 21 |
Mar 20 |
Mar 19 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
29.27 |
30.70 |
25.82 |
21.23 |
20.75 |
|
| Diluted EPS (Rs.) |
29.23 |
30.70 |
25.80 |
21.21 |
20.74 |
|
| Cash EPS (Rs.) |
34.02 |
34.48 |
28.59 |
24.76 |
23.05 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
163.39 |
141.11 |
116.03 |
95.72 |
84.06 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
163.39 |
141.11 |
116.03 |
95.72 |
84.06 |
|
| Dividend / Share(Rs.) |
7.35 |
6.01 |
5.50 |
2.87 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
97.85 |
89.44 |
81.66 |
75.14 |
65.19 |
|
| PBDIT/Share (Rs.) |
38.41 |
37.74 |
31.47 |
27.27 |
26.63 |
|
| PBIT/Share (Rs.) |
33.66 |
33.95 |
28.70 |
23.97 |
24.33 |
|
| PBT/Share (Rs.) |
32.13 |
33.73 |
28.64 |
23.83 |
22.67 |
|
| Net Profit/Share (Rs.) |
29.27 |
30.69 |
25.82 |
21.45 |
20.75 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
39.25 |
42.19 |
38.53 |
36.29 |
40.84 |
|
| PBIT Margin (%) |
34.39 |
37.96 |
35.14 |
31.89 |
37.31 |
|
| PBT Margin (%) |
32.83 |
37.71 |
35.07 |
31.71 |
34.77 |
|
| Net Profit Margin (%) |
29.90 |
34.31 |
31.61 |
28.54 |
31.83 |
|
| Return on Networth / Equity (%) |
17.91 |
21.75 |
22.25 |
22.41 |
24.68 |
|
| Return on Capital Employed (%) |
18.30 |
23.26 |
24.19 |
24.40 |
28.35 |
|
| Return on Assets (%) |
14.29 |
19.40 |
19.97 |
19.63 |
19.40 |
|
| Total Debt/Equity (X) |
0.14 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Asset Turnover Ratio (%) |
0.54 |
0.62 |
63.18 |
68.78 |
60.97 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.95 |
3.49 |
2.93 |
3.01 |
1.89 |
|
| Quick Ratio (X) |
1.72 |
2.98 |
2.48 |
2.57 |
1.63 |
|
| Inventory Turnover Ratio (X) |
1.54 |
1.57 |
17.10 |
15.59 |
12.00 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
19.57 |
21.30 |
13.37 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
17.42 |
19.23 |
11.59 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
80.43 |
78.70 |
86.63 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
82.58 |
80.77 |
88.41 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
8,048.53 |
9,320.83 |
8,174.56 |
4,938.54 |
8,850.50 |
|
| EV/Net Operating Revenue (X) |
6.05 |
7.67 |
7.37 |
4.84 |
9.87 |
|
| EV/EBITDA (X) |
15.41 |
18.17 |
19.13 |
13.34 |
24.17 |
|
| MarketCap/Net Operating Revenue (X) |
5.85 |
7.70 |
7.40 |
4.90 |
9.88 |
|
| Retention Ratios (%) |
0.00 |
80.42 |
78.69 |
86.62 |
0.00 |
|
| Price/BV (X) |
3.50 |
4.88 |
5.21 |
3.85 |
7.66 |
|
| Price/Net Operating Revenue |
5.85 |
7.70 |
7.40 |
4.90 |
9.88 |
|
| Earnings Yield |
0.05 |
0.04 |
0.04 |
0.06 |
0.03 |
|
Source : Dion Global Solutions Limited
